[Ip-health] (no subject)

[Sean Flynn]

This is a multi-part message in MIME format.
--
[ Picked text/plain from multipart/alternative ]
Lawyering for Access:

Legal Strategies to Improve Access to Affordable Pharmaceuticals



12:30 pm - Friday, October 16, 2009

American University - Washington College of Law - Room 602



PIJIP and Prescription Policy Choices are co-hosting "Lawyering for
Access" to discuss steps state governments have taken to control
pharmaceutical costs, as well as the roles of both legislation and
litigation in pharmaceutical policy.

Topics will include the recent $2.3 billion Pfizer settlement;
innovative state legislation being considered around the country;
federal appellate litigation by the pharmaceutical industry asserting a
First Amendment right to access prescription records for marketing
purposes; litigation regarding deceptive marketing practices; and the
implications of health care reform for access to medicines and the use
of health information.

12:30

Lunch Served

12:45

Panel 1: State Legislative Efforts

*         Sean Flynn, Associate Director, Program on Information Justice
& Intellectual Property

Prescription Data Mining Regulation and the First Amendment

*         Ann Woloson, Director, Prescription Policy Choices

Sharon Treat, Director, National Legislative Association on Prescription
Drug Prices

The Conception of Maine's Marketing to Minors Law

*         Robin Lunge, Legislative Counsel, Vermont State Legislature

The Passage and Amendment of Vermont's Prescriber Payment Disclosure Law

1:35

Break

1:45

Panel 2: Pharmaceutical Litigation: Safety, Pricing, and Promotion

*         Allison Zieve, Director, Public Citizen Litigation Group

Wyeth v. Levine - Preserving a State Right of Action in Pharmaceutical
Litigation

*         Wells Wilkinson, Director, Prescription Access Litigation

The Role of Private Litigation in Policing Pharma Practices

*         Michael Loucks, Acting U.S. Attorney for the District of
Massachusetts

U.S. v Pharmacia & Upjohn - Prosecuting Pharmaceutical Fraud under
Criminal and Civil Law

2:45

Reception